I. King
Impact in
- Biotechnology top 2%
- Cancer Research and Treatments
- Genetics top 10%
- Virus-based gene therapy research
Papers in
-
- Cancer therapeutics and mechanisms 2
- Oncology 5
- Cancer Treatment and Pharmacology 2
- Co-authors
- Alan C. Sartorelli (3 shared papers)Xiaobo Luo (2 shared papers)David Bermudes (3 shared papers)Martina Ittensohn (2 shared papers)Jeremy A. Pike (2 shared papers)Caroline Clairmont (2 shared papers)Stephen M. Brecher (1 shared paper)K. C. Lee (1 shared paper)
- Journals
- Antimicrobial Agents and Chemotherapy (1 paper)Bioorganic & Medicinal Chemistry Letters (1 paper)The Journal of Infectious Diseases (1 paper)Journal of Cellular Physiology (1 paper)Chemical Research in Toxicology (1 paper)
- Partner nations
- United StatesFranceUnited Kingdom
In The Last Decade
I. King
12 papers receiving 558 citations
Peers
Comparison fields: 5 of 67
- Biotechnology 320
- Genetics 174
- Biomedical Engineering 222
- Hepatology 27
- Virology 13
Countries citing papers authored by I. King
This map shows the geographic impact of I. King's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by I. King with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites I. King more than expected).
Fields of papers citing papers by I. King
This network shows the impact of papers produced by I. King. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by I. King. The network helps show where I. King may publish in the future.
Co-authors
The 25 scholars most cited alongside I. King, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2000 | 299 | |
| 2 | 1990 | 94 | |
| 3 | 2001 | 55 | |
| 4 | 2001 | 38 | |
| 5 | Differentiation of WEHI-3B D+ myelomonocytic leukemia cells induced by ectopic expression of the protooncogene c-jun. | 1994 | 28 |
| 6 | Epidermal growth factor receptor gene expression, protein kinase activity, and terminal differentiation of human malignant epidermal cells. | 1989 | 26 |
| 7 | Interaction of beta-L-2',3'-dideoxy-2',3'-didehydro-5-fluoro-CTP with human immunodeficiency virus-1 reverse transcriptase and human DNA polymerases: implications for human immunodeficiency virus drug design. | 1998 | 14 |
| 8 | 1998 | 11 | |
| 9 | 2000 | 4 | |
| 10 | 2011 | 3 | |
| 11 | 2010 | 2 | |
| 12 | Antitumor effect of keto-diepoxides isolated from the fungus Nattrassia mangiferae. | 1995 | 2 |
About I. King
I. King is a scholar working on Molecular Biology, Oncology, Organic Chemistry, Biotechnology and Infectious Diseases, having authored 12 papers that have together received 576 indexed citations. Recurring topics across this work include Cancer Research and Treatments (3 papers), Cancer Treatment and Pharmacology (2 papers), HIV/AIDS drug development and treatment (2 papers), Synthesis and biological activity (2 papers), Cancer therapeutics and mechanisms (2 papers), Virus-based gene therapy research (2 papers), Hepatitis B Virus Studies (1 paper) and Microtubule and mitosis dynamics (1 paper). The work is most often cited by research in Biotechnology (320 citations), Genetics (174 citations), Biomedical Engineering (222 citations), Hepatology (27 citations) and Virology (13 citations). I. King has collaborated with scholars based in United States, France and United Kingdom. Frequent co-authors include Alan C. Sartorelli, Xiaobo Luo, David Bermudes, Martina Ittensohn, Jeremy A. Pike, Caroline Clairmont, Stephen M. Brecher, K. C. Lee, K. Brooks Low and Z. Li. Their work appears in journals such as Antimicrobial Agents and Chemotherapy, Bioorganic & Medicinal Chemistry Letters, The Journal of Infectious Diseases, Journal of Cellular Physiology and Chemical Research in Toxicology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.